SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001126234-24-000055
Filing Date
2024-04-22
Accepted
2024-04-22 16:30:56
Documents
16
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A nlnk-20231231.htm   iXBRL 10-K/A 122046
2 EX-31.3 lumo-20231231x10kxex313.htm EX-31.3 4279
3 EX-31.4 lumo-20231231x10kxex314.htm EX-31.4 4372
4 EX-97.1 lumo-20231231x10kxex971.htm EX-97.1 38084
  Complete submission text file 0001126234-24-000055.txt   373414

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nlnk-20231231.xsd EX-101.SCH 1908
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nlnk-20231231_lab.xml EX-101.LAB 33589
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nlnk-20231231_pre.xml EX-101.PRE 19534
19 EXTRACTED XBRL INSTANCE DOCUMENT nlnk-20231231_htm.xml XML 5322
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35342 | Film No.: 24861563
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)